Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
Treatment options for metastatic pancreatic ductal adenocarcinoma (mPDAC) patients remain limited, meaning that death within weeks of diagnosis unfortunately remains a common occurrence. Whilst metastases from other malignancy sites, such as colorectal and breast, are amenable to resection in select...
Saved in:
Main Authors: | James M. Halle-Smith, Lewis A. Hall, Sarah F. Powell-Brett, Nabeel Merali, Adam Frampton, Keith J. Roberts |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Clinical Surgical Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2773160X23000120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
by: Neil Daniel, et al.
Published: (2024-10-01) -
Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients
by: Xiao Liang, et al.
Published: (2024-12-01) -
Microbiome in pancreatic cancer – What is new in 2024?
by: E. Hohmann, et al.
Published: (2024-10-01) -
Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01) -
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)